NO942756L - Treatment of glaucoma - Google Patents
Treatment of glaucomaInfo
- Publication number
- NO942756L NO942756L NO942756A NO942756A NO942756L NO 942756 L NO942756 L NO 942756L NO 942756 A NO942756 A NO 942756A NO 942756 A NO942756 A NO 942756A NO 942756 L NO942756 L NO 942756L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- glaucoma
- retinal
- eye
- salts
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Det blir beskrevet anvendelsen av forbindelser med formel (I), \ (D, hvor er -CH (la) eller X er CH CH3 CH T ----CH---- (lb ), karboksy gruppen er direkte bundet til cyklopentylrlngen l det tilfellet hvor X = (la) og deres salter, ved fremstil- lingen av .farmasøytiske sammensetninger for behandling av glaucoma, for økning av bevegelsen av (retlnalt) intra-okulart fluid, for behandling av vasospastlske tilstander i øyet og for behandling . av diabetisk retlnopatl og også tilsvarende oftalmiske sammen-setninger.It is described the use of compounds of formula (I), \ (D, wherein is -CH (Ia) or X is CH CH3 CH T ---- CH ---- (1b), the carboxy group is directly bonded to the cyclopentyl ring In the case where X = (1a) and their salts, in the preparation of pharmaceutical compositions for the treatment of glaucoma, for increasing the movement of (retinal) intraocular fluid, for the treatment of vasospastic conditions of the eye and for treatment. of diabetic retinopathy and also similar ophthalmic compositions.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH45992 | 1992-02-17 | ||
PCT/US1993/001431 WO1993015732A1 (en) | 1992-02-17 | 1993-02-17 | Treatment of glaucoma |
Publications (2)
Publication Number | Publication Date |
---|---|
NO942756L true NO942756L (en) | 1994-07-22 |
NO942756D0 NO942756D0 (en) | 1994-07-22 |
Family
ID=4187501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO942756A NO942756D0 (en) | 1992-02-17 | 1994-07-22 | Treatment of glaucoma |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0626846A1 (en) |
JP (1) | JPH07504099A (en) |
AU (1) | AU3722493A (en) |
CA (1) | CA2128324A1 (en) |
IL (1) | IL104755A0 (en) |
NO (1) | NO942756D0 (en) |
WO (1) | WO1993015732A1 (en) |
ZA (1) | ZA931063B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0743852B1 (en) * | 1994-02-08 | 2005-07-27 | Novartis AG | Treatment of normotensive glaucoma with valsartan |
EP0750500A1 (en) * | 1994-03-17 | 1997-01-02 | Ciba-Geigy Ag | Treatment of diabetic nephropathy with valsartan |
GB9613470D0 (en) | 1996-06-27 | 1996-08-28 | Ciba Geigy Ag | Small solid oral dosage form |
KR100616466B1 (en) | 1998-08-17 | 2006-08-29 | 센주 세이야꾸 가부시키가이샤 | Preventives/remedies for glaucoma |
KR20010074838A (en) * | 1998-08-20 | 2001-08-09 | 요시다 쇼지 | Preventives or remedies for eye circulatory failure |
BR0010084A (en) * | 1999-04-28 | 2002-01-15 | Takeda Chemical Industries Ltd | Pharmaceutical composition, processes to prevent, treat or inhibit the development of simple retinopathy or proliferative retinopathy, and to increase retinal potential or mammalian retinal edema, and, use of a compound |
TW200304812A (en) * | 2002-03-08 | 2003-10-16 | Sankyo Co | An eye drop containing a tetrazole derivative |
FR2878522B1 (en) * | 2004-12-01 | 2008-04-18 | Merck Sante Soc Par Actions Si | NEW SPECIFIC INHIBITORS OF CASPAS-10 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5036048A (en) * | 1986-03-07 | 1991-07-30 | Schering Corporation | Angiotensin II receptor blockers as antiglaucoma agents |
ATE134624T1 (en) * | 1990-02-19 | 1996-03-15 | Ciba Geigy Ag | ACYL COMPOUNDS |
TW201738B (en) * | 1990-03-20 | 1993-03-11 | Sanofi Co | |
FR2672891B1 (en) * | 1991-02-20 | 1994-02-18 | Synthelabo | DERIVATIVES OF 3-PYRAZOLONES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION. |
-
1993
- 1993-02-16 ZA ZA931063A patent/ZA931063B/en unknown
- 1993-02-16 IL IL104755A patent/IL104755A0/en unknown
- 1993-02-17 JP JP5514345A patent/JPH07504099A/en active Pending
- 1993-02-17 CA CA002128324A patent/CA2128324A1/en not_active Abandoned
- 1993-02-17 EP EP93906040A patent/EP0626846A1/en not_active Ceased
- 1993-02-17 AU AU37224/93A patent/AU3722493A/en not_active Abandoned
- 1993-02-17 WO PCT/US1993/001431 patent/WO1993015732A1/en not_active Application Discontinuation
-
1994
- 1994-07-22 NO NO942756A patent/NO942756D0/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2128324A1 (en) | 1993-08-19 |
ZA931063B (en) | 1993-09-23 |
WO1993015732A1 (en) | 1993-08-19 |
NO942756D0 (en) | 1994-07-22 |
JPH07504099A (en) | 1995-05-11 |
IL104755A0 (en) | 1993-06-10 |
EP0626846A1 (en) | 1994-12-07 |
AU3722493A (en) | 1993-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES476496A1 (en) | Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof, and process for their manufacture. | |
EP1225168B8 (en) | Prostaglandin-F-2 alpha derivative for the treatment of glaucoma or ocular hypertension | |
ES8705886A1 (en) | Thiazolidinedione derivatives, their production and use. | |
DE69527799D1 (en) | MEDICINES FOR INCREASING CHAMBER WATER OUTFLOW IN GLAUCOMA TREATMENT | |
AR040806A1 (en) | DERIVATIVES OF PIPERIDI-2-ONA 1.6 DISUSTITUTED, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT AND TREATMENT METHOD | |
DK0437030T3 (en) | Use of 4-substituted imidazoles to reduce intraocular pressure | |
NO942756L (en) | Treatment of glaucoma | |
CA2081113A1 (en) | Thiazolidine-2,4-dione derivative, salt thereof, and production of the same | |
FI881104A0 (en) | Process for the preparation of benzoxazine derivatives for use as antidiabetic agents | |
NO873722D0 (en) | NEW DERIVATIVES OF 4,5-DIHYDRO-OXSAZOLES, AND THE PROCEDURE FOR THEIR PREPARATION. | |
EP0420606A3 (en) | Use of 2-cycloalkylamino oxazolines for reducing or maintaining intraocular pressure | |
EP0345028A3 (en) | Treatment of glaucoma using phosphodiesterase inhibitor | |
KR960003719A (en) | Glaucoma Therapeutics and Intraocular Pressure Drops | |
AU658175B2 (en) | Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients | |
AU6291494A (en) | Benzothiazole compound, process for producing the same, and use thereof | |
NO941932L (en) | New [1- (1H-imidazol-4-yl) -alkylA-benzene derivatives, process of their preparation, and eye preparations containing them as active ingredient | |
NO20020475D0 (en) | 2-aminotetraline derivatives for glaucoma therapy | |
EP0020765A4 (en) | Medicament against glaucoma. | |
AU6101890A (en) | Therapeutic agents for the treatment of peptic ulcer disease | |
JPS55102516A (en) | Remedy for glaucoma | |
IE791205L (en) | Novel oxothia compounds, processes for their preparation,¹pharmaceutical preparations containing these compounds and¹such compounds for therapeutic use | |
ES462982A1 (en) | 8-azoprostanoic acid derivatives | |
EP1300150A3 (en) | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |